Loading...
6th Antibody Industrial Symposium 2018 - TARGETS FOR MABS :
Innovative Approaches for their Discovery & Validation June 25 - 26 2018 / Montpellier | France
News Twitter

Committees

Scientific Committee

Andreï Turtoi

Andreï Turtoi
Head of Tumor Microenvironment and Resistance to Treatment Lab
Institut de Recherche en Cancérologie de Montpellier

Alain Beck

Alain Beck
Senior Director, NBEs Analytical Chemistry
Centre d’Immunologie Pierre Fabre

André Pèlegrin

André Pèlegrin
Deputy Director LabEx MAbImprove, Group Leader
Institut de Recherche en Cancérologie de Montpellier

Thierry Wurch

Thierry Wurch
Director – Immuno-Oncology External Research & Innovation
Institut de Recherches SERVIER

Pierre Martineau

Pierre Martineau
Group Leader & IRCM Deputy Director
Institut de Recherche en Cancérologie de Montpellier

Roland Beliard

Roland Beliard
CEO
LFB Biomanufacturing
Business Development Manager
LFB Biotechnologies

Sylvain Huille

Sylvain Huille
Head of Formulation, Biotherapeutics
Sanofi

Nicolas Poirier

Nicolas Poirier
Chief Scientific Officer
OSE Immunotherapeutics

Ana Antunes

Ana Antunes
Science and Communication Officer
MabDesign

Jérôme Tiollier

Jérôme Tiollier
EVP Chief Development Officer
INNATE PHARMA

François Romagné

François Romagné
Scientific Director
MI-mAbs

Organisation committee

André Pèlegrin

André Pèlegrin
Deputy Director LabEx MAbImprove, Group Leader
Institut de Recherche en Cancérologie de Montpellier

Pierre Martineau

Pierre Martineau
Group Leader & IRCM Deputy Director
Institut de Recherche en Cancérologie de Montpellier

Nicolas Groux

Nicolas Groux
Chief Operating Officer
MabDesign

Organization contact
Ana Antunes
17 rue Crépet
69007 Lyon
+33 (0)4 78 02 39 91
ana-sofia.antunes@mabdesign.fr